Alveolar Macrophage-mediated Killing of Pneumocystis carinii f. sp. muris Involves Molecular Recognition by the Dectin-1 β-Glucan Receptor

Journal of Experimental Medicine

Volumn 198, Issue 11, 2003, Pages 1677-1688

  Steele, Chad ^a   Marrero, Luis ^b   Swain, Steve ^c   Harmsen, Allen G ^c   Zheng, Mingquan ^a   Brown, Gordon D ^d   Gordon, Siamon ^d   Shellito, Judd E ^b   Kolls, Jay K ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Chemokine; Innate; Leukocyte; Lung; Yeast

Indexed keywords

ANTIBODY; BETA GLUCAN; DECTIN 1; DECTIN 1 ANTIBODY; DECTIN 1 BETA GLUCAN RECEPTOR; FC RECEPTOR; HYDROGEN PEROXIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CELL WALL; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HOST RESISTANCE; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; MALE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; OPSONIZATION; PARASITE SURVIVAL; PHAGOCYTOSIS; PNEUMOCYSTIS CARINII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RAT;

ANIMALS; CELL LINE; MACROPHAGES, ALVEOLAR; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MONOKINES; NERVE TISSUE PROTEINS; PHAGOCYTOSIS; PNEUMOCYSTIS CARINII; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC;

EID: 0345167827     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030932     Document Type: Article

References (45)

1. Ives, N.J., B.G. Gazzard, and P.J. Easterbrook. 2001. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J. Infect. 42:134-139.
2. Morris, A., R.M. Wachter, J. Luce, J. Turner, and L. Huang. 2003. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS. 17:73-80.
3. Sullivan, J.H., R.D. Moore, J.C. Keruly, and R.E. Chaisson. 2000. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am. J. Respir. Crit. Care Med. 162:64-67.
4. Mayaud, C., A. Parrot, and J. Cadranel. 2002. Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients. Eur. Respir. J. Suppl. 36:28s-39s.
5. Vassallo, R., C.F. Thomas, Jr., Z. Vuk-Pavlovic, and A.H. Limper. 1999. Alveolar macrophage interactions with Pneumocystis carinii. J. Lab. Clin. Med. 133:535-540.
6. Limper, A.H., J.S. Hoyte, and J.E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99:2110-2117.
7. Koziel, H., Q. Eichbaum, B.A. Kruskal, P. Pinkston, R.A. Rogers, M.Y. Armstrong, F.F. Richards, R.M. Rose, and R.A. Ezekowitz. 1998. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor down-regulation. J. Clin. Invest. 102:1332-1344.
8. O'Riordan, D.M., J.E. Standing, and A.H. Limper. 1995. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect. Immun. 63:779-784.
9. Hoffman, O.A., J.E. Standing, and A.H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 150:3932-3940.
10. Vassallo, R., J.E. Standing, and A.H. Limper. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164:3755-3763.
11. Vassallo, R., J. Standing, and A.H. Limper. 1999. Beta-glucan from Pneumocystis carinii stimulates TNF alpha release from alveolar macrophages. J. Eukaryot. Microbiol. 46:145S.
12. Hidalgo, H.A., R.J. Helmke, V.F. German, and J.A. Mangos. 1992. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60:1-7.
13. Laursen, A.L., B. Moller, J. Rungby, C.M. Petersen, and P.L. Andersen. 1994. Pneumocystis carinii-induced activation of the respiratory burst in human monocytes and macrophages. Clin. Exp. Immunol. 98:196-202.
14. Pesanti, E.L. 1984. Pneumocystis carinii: oxygen uptake, antioxident enzymes, and susceptibility to oxygen-mediated damage. Infect. Immun. 44:7-11.
15. Koziel, H., X. Li, M.Y. Armstrong, F.F. Richards, and R.M. Rose. 2000. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am. J. Respir. Cell Biol. 23:452-459.
16. Wakefield, A.E. 2002. Pnemnocystis carinii. Br. Med. Bull. 61:175-188.
17. Downing, J.F., D.L. Kachel, R. Pasula, and W.J. Martin. 1999. Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine and tumor necrosis factor dependent mechanisms. Infect. Immun. 67:1347-1352.
18. Zheng, M., J.E. Shellito, L. Marrero, Q. Zhong, S. Julian, P. Ye, V. Wallace, P. Schwarzenberger, and J.K. Kolls. 2001. CD4(+) T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108:1469-1474.
19. Steele, C., M. Zheng, E. Young, L. Marrero, J.E. Shellito, and J.K. Kolls. 2002. Increased host resistance against Pneumocystis carinii pneumonia in gammadelta T-cell-deficient mice: protective role of gamma interferon and CD8(+) T cells. Infect. Immun. 70:5208-5215.
20. Brown, G.D., P.R. Taylor, D.M. Reid, J.A. Willment, D.L. Williams, L. Martinez-Pomares, S.Y.C. Wong, and S. Gordon. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196:407-412.
21. Brown, G.D., and S. Gordon. 2001. Innate recognition: a new receptor for β-glucans. Nature. 413:36-37.
22. Lee, S.J., S. Evers, D. Roeder, A.F. Parlow, J. Risteli, L. Risteli, Y.C. Lee, T. Feizi, H. Langen, and M.C. Nussenzweig. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science. 295:1898-1901.
23. Shellito, J., V.V. Suzara, W. Blumenfeld, J.M. Beck, H.J. Steger, and T.H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85:1686-1693.
24. Kolls, J.K., S. Habetz, M.K. Shean, C. Vazquez, J.A. Brown, D. Lei, P. Schwarzenberger, P. Ye, S. Nelson, W.R. Summer, et al. 1999. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J. Immunol. 162:2890-2894.
25. Ezekowitz, R.A., D.J. Williams, H. Koziel, M.Y. Armstrong, A. Warner, F.F. Richards, and R.M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature. 351:155-158.
26. Brown, G.D., J. Herre, D.L. Williams, J.A. Willment, A.S.J. Marshall, and S. Gordon. 2003. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197:1119-1124.
27. Masur, H., and T.C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J. Exp. Med. 147:157-170.
28. Faulkner, K.M., S.I. Liochev, and I. Fridovich. 1994. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem. 269:23471-23476.
29. 2 in NR8383 alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 23:748-754.
30. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:927-930.
31. Beck, J.M., and A.G. Harmsen. 1998. Lymphocytes in host defense against Pneumocystis carinii. Semin. Respir. Infect. 13: 330-338.
32. Marcotte, H., D. Levesque, K. Delanay, A. Bourgeault, D.R. de la, S. Brochu, and M.C. Lavoie. 1996. Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173:1034-1037.
33. Gigliotti, F., and A.G. Harmsen. 1997. Pneumocystis carinii host origin defines the antibody specificity and protective response induced by immunization. J. Infect. Dis. 176:1322-1326.
34. Guillot, J., C. Demanche, J.P. Hugot, M. Berthelemy, A.E. Wakefield, E. Dei-Cas, and R. Chermette. 2001. Parallel phylogenies of Pneumocystis species and their mammalian hosts. J. Eukaryot. Microbiol. S1:113s-115s.
35. Stehle, S.E., R.A. Rogers, A.G. Harmsen, and R.A.B. Ezekowitz. 2000. A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro. Scand. J. Immunol. 52:131-137.
36. Fraser, I.P., K. Takahashi, H. Koziel, B. Fardin, A. Harmsen, and R.A.B. Ezekowitz. 2000. Pneumocystis carinii enhances soluble mannose receptor production by macrophages. Microbes Infect. 2:1305-1310.
37. Reeves, E.P., H. Lu, H.L. Jacobs, C.G. Messina, S. Bolsover, G. Gabella, E.O. Potma, A. Warley, J. Roes, and A.W. Segal. 2002. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 416:291-297.
38. Gigliotti, F. 1992. Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 165:329-336.
39. Lee, S.J., N.Y. Zheng, M. Clavijo, and M.C. Nussenzweig. 2003. Normal host defense during systemic candidiasis in mannose receptor-deficient mice. Infect. Immun. 71:437-445.
40. Marodi, L., H.M. Korchak, and R.B. Johnston. 1991. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 146:2783-2789.
41. Swain, S.D., S.J. Lee, M.C. Nussenzweig, and A.G. Harmsen. 2003. Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo. Infect. Immun. 71:6213-6221.
42. Matsumoto, Y., S. Matsuda, and T. Tegoshi. 1989. Yeast glucan in the cyst wall of Pneumocystis carinii. J. Protozool. 36:21s-22s.
43. De Stegano, J.A., M.T. Cushion, V. Puvanesarajah, and P.D. Walzer. 1990. Analysis of Pneumocystis carinii cyst wall. II. Sugar composition. J. Protozool. 37:436-441.
44. Ariizumi, K., G.L. Shen, S. Shikano, S. Xu, R. Ritter, K. Kumamoto, D. Edelbaum, A. Morita, P.R. Bergstresser, and A. Takashima. 2000. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 275:20157-20167.
45. Deresinski, S.C., and D.A. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457.